(Q54537693)

31 May 2018

title

Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients. (English)

1 reference

31 May 2018

triple-negative breast cancer

main subject

1 reference

9

1 reference

31 May 2018

Paolo Radice

10

1 reference

31 May 2018

Marco Colleoni

object named as

Marco Colleoni

7

0 references

Giuseppe Viale

11

object named as

Giuseppe Viale

1 reference

31 May 2018

author name string

Caterina Fumagalli

1

1 reference

31 May 2018

Giancarlo Pruneri

2

1 reference

31 May 2018

Paola Possanzini

3

1 reference

31 May 2018

Michela Manzotti

4

1 reference

31 May 2018

Monica Barile

5

1 reference

31 May 2018

Irene Feroce

6

1 reference

31 May 2018

Bernardo Bonanni

8

1 reference

31 May 2018

Massimo Barberis

12

1 reference

31 May 2018

language of work or name

English

0 references

publication date

8 January 2012

1 reference

31 May 2018

Breast Cancer Research and Treatment

published in

1 reference

31 May 2018

volume

134

1 reference

31 May 2018

issue

1

1 reference

31 May 2018

page(s)

131-137

1 reference

31 May 2018

Triple-negative breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

What is triple-negative breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Therapeutic strategies for triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Triple-negative breast cancer: role of specific chemotherapy agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Platinum-based chemotherapy in triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Brca1 controls homology-directed DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Cellular functions of the BRCA tumour-suppressor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

A sensitive test for the detection of specific DSB repair defects in primary cells from breast cancer specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

DNA binding and nucleotide flipping by the human DNA repair protein AGT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

MGMT: its role in cancer aetiology and cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Pattern of expression of genes linked to epigenetic silencing in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Expression and prognostic significance of O6-methylguanine-DNA methyltransferase in hepatocellular, gastric, and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

BRCA1, a potential predictive biomarker in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Triple-negative breast cancer: disease entity or title of convenience?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Genomic and molecular profiling predicts response to temozolomide in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

Evaluation of O6-methylguanine-DNA methyltransferase by immunohistochemistry: best clinical and research practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

DNA damage and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1945-9

10.1007/S10549-011-1945-9

21 January 2018

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018